Evidence map›Paper›PMID 30200369›Full record

ArticleGenes2018

Human Vascular Endothelial Growth Factor A

Emmi Kokki, Tommi Karttunen, Venla Olsson, Kati Kinnunen, Seppo Ylä-Herttuala

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Haplotypes ofDisease markers · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Emmi KokkiA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70150 Kuopio, Finland. emmi.kokki@uef.fi.ORCID 0000-0003-1900-0134
Tommi KarttunenDepartment of Ophthalmology, Kuopio University Hospital, 70210 Kuopio, Finland. tommi.karttunen@kuh.fi.
Venla OlssonA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70150 Kuopio, Finland. venla.olsson@uef.fi.
Kati KinnunenDepartment of Ophthalmology, Kuopio University Hospital, 70210 Kuopio, Finland. kati.kinnunen@kuh.fi.
Seppo Ylä-HerttualaA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70150 Kuopio, Finland. seppo.ylaherttuala@uef.fi.ORCID 0000-0001-7593-2708
University of Eastern Finland · FIKuopio University Hospital · FI

Funding

Academy of Finland -Eye and Tissue Bank Foundation -Otto A Malm Foundation -Suomen Kulttuurirahasto Anja ja Mirja Tissarin rahastoThe Diabetes Research Foundations -
6 · The paper itself

Abstract

Vascular endothelial growth factor (VEGF) expression induces age-related macular degeneration (AMD), which is a common vision-threatening disease due to choroidal neovascularization and a fibrovascular membrane. We describe a mouse model of neovascular AMD with the local expression of human VEGF-A

Indexed as

adenovirusage-related macular degenerationanimal modelgene therapygene transferneovascularizationsubretinalvascular endothelial growth factor

Identifiers

PMID30200369
PMCPMC6162490
OpenAlexW2889537918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.